mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.5 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.5 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.5 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |